How Long Does 5mg Oxycodone Stay in Your System?

A single 5 mg dose of immediate-release oxycodone leaves your bloodstream relatively quickly, with a half-life averaging about three and a half hours, meaning most of the drug is gone from blood within roughly 20 hours. Detection on a drug test, though, is a different question: urine screens can pick up oxycodone or its breakdown products for about 30 to 40 hours after one dose. The gap between when you stop feeling the drug and when a lab can still find it matters, and several personal factors can stretch or shrink that window.

How Fast Your Body Processes a 5 mg Dose

After you swallow a 5 mg oxycodone tablet, your gut absorbs it efficiently. Studies in patients given oral oxycodone found a mean bioavailability of about 87 percent, meaning most of the drug reaches your bloodstream rather than being lost during digestion.¹ For a 5 mg pill, that translates to roughly 4.3 mg of active oxycodone circulating through your body at peak.

The elimination half-life of oral oxycodone averages about 3.5 hours, with individual variation ranging from roughly 2 to 5 hours.¹ A half-life is the time it takes for the amount in your blood to drop by half. After one half-life (about 3.5 hours), you have roughly 2.15 mg worth of oxycodone left in circulation. After two half-lives (about 7 hours), roughly 1 mg. By five to six half-lives, somewhere around 18 to 21 hours, the amount remaining in your blood is so small that standard blood tests would struggle to detect it. For a 5 mg dose specifically, the low starting amount means the drug clears from blood faster than it would from a 30 mg extended-release tablet. This is the reason you often hear a rough estimate of “about a day” for blood clearance after a small dose.

Urine Detection Windows

Urine tests are the most common way oxycodone use is screened for in clinical and workplace settings, and they stay positive longer than blood tests because your kidneys concentrate the drug and its metabolites in urine over hours. In a controlled study where volunteers received a single oral dose of oxycodone, the parent drug appeared in urine within two hours and peaked between 3 and 19 hours. At a standard cutoff concentration of 50 ng/mL, oxycodone itself was detectable for about 30 hours, while its major metabolites noroxycodone and oxymorphone remained detectable for roughly 40 hours.²

Those numbers come from a single, controlled dose, which is essentially what a one-time 5 mg dose is. If you have been taking oxycodone regularly rather than just once, your urine detection window will be longer because the drug and its metabolites build up. For a single 5 mg pill taken by someone with normal kidney and liver function, you can reasonably expect a urine test to come back positive for one to two days, with the outer edge around 40 hours being driven by metabolites rather than oxycodone itself.

The cutoff concentration matters here. Standard immunoassay panels for opioids often use a 300 ng/mL cutoff for the general opiate class, but confirmatory tests specifically targeting oxycodone typically use a lower threshold of 100 or even 50 ng/mL. A lower cutoff means the test catches smaller traces, which extends the apparent detection window by several hours.

Saliva and Blood

Saliva testing is used less often than urine but is growing in workplace and roadside settings because collection is quick and hard to tamper with. Oxycodone shows up in saliva in proportions that resemble blood plasma more than urine: the parent drug dominates over its metabolites, unlike in urine where metabolites can outnumber oxycodone itself.³ The same study found that oxycodone concentrations in saliva can be far higher than in plasma, sometimes by a factor of a thousand, likely because of drug residue in the mouth or active secretion from salivary glands. That means a saliva swab can pick up oxycodone for a comparable duration as urine, roughly one to three days, although the exact window after a single 5 mg dose has not been pinned down as precisely as the urine window.

Blood (or serum/plasma) detection is the shortest window. Based on the 3.5-hour half-life and the low starting concentration from a 5 mg dose, blood levels drop below typical detection thresholds within about 12 to 24 hours. Blood draws are mainly used in emergency departments and forensic investigations rather than routine drug screening, because the window is so narrow and the procedure is more invasive.

Hair testing can extend the detection window dramatically, to 90 days or more, but hair tests are looking for chronic or repeated use. A single 5 mg dose is unlikely to deposit enough drug in a hair follicle to register at standard cutoffs, so hair testing is not a practical concern here.

Why Detection Times Vary From Person to Person

The numbers above are averages. Your actual clearance speed depends on several factors that can shift the timeline by hours in either direction.

Age

Older adults tend to clear oxycodone more slowly. Research on age-related pharmacokinetics has found that plasma concentrations, total drug exposure, and half-life are all higher in older adults compared to younger patients, while clearance rates are lower.⁴ If you are over 65, a 5 mg dose may linger at detectable levels for several hours longer than in a 25-year-old.

Kidney and Liver Function

Your liver breaks oxycodone down and your kidneys flush the products out. Impairment in either organ slows the process. Oxycodone and its active metabolites are cleared renally, and that clearance can be substantially reduced in people with kidney disease, especially older patients.⁵ In studies of patients with moderate kidney or liver impairment, peak oxycodone concentrations and overall drug exposure were up to roughly double what they are in healthy volunteers.⁶ Twice the exposure roughly translates to an extra half-life’s worth of detectable time, so you might add three to four hours to the blood clearance window and proportionally more to urine.

Interestingly, for people on dialysis with severe kidney disease, one study found that oxycodone’s half-life stayed relatively short and could be used at usual doses, though the metabolites behaved differently.⁷ The takeaway is that kidney and liver problems don’t always predict longer detection times in a simple, linear way; it depends on the severity and which organ is affected.

Genetic Differences in Metabolism

Oxycodone is broken down in the liver primarily by two enzyme families called CYP3A and CYP2D6. Genetic variation in these enzymes affects how quickly you convert oxycodone into its metabolites. A large study of clinical urine drug tests found a nearly seven-fold difference in metabolite ratios between people who are ultrarapid CYP2D6 metabolizers and those who are poor metabolizers.⁸ Poor metabolizers had oxycodone-positive urine specimens that were about five times more likely to show no oxymorphone at all, because their bodies barely made that particular metabolite.

What this means in practice: if you are a poor metabolizer, oxycodone itself may stick around a bit longer (it’s not being converted as efficiently), and the pattern of metabolites in your urine will look different. Conversely, an ultrarapid metabolizer chews through oxycodone faster but generates more of the active metabolite oxymorphone. Neither scenario changes the detection window dramatically for a single 5 mg dose, but it can matter for confirmatory testing, which looks at the ratio of oxycodone to its metabolites to verify that you actually took oxycodone and not something else.

Medications That Slow Oxycodone Clearance

Because oxycodone depends on two liver enzyme pathways, drugs that block those enzymes can slow its elimination. The critical finding from pharmacokinetic research is that blocking just one pathway usually does not change oxycodone blood levels much, because the other pathway picks up the slack. Blocking both pathways at the same time is a different story. In a study where volunteers took the CYP2D6 inhibitor paroxetine (an antidepressant) together with the CYP3A4 inhibitor itraconazole (an antifungal), oxycodone’s total blood exposure nearly tripled and its peak concentration roughly doubled.⁹ Taking paroxetine alone, which only blocks CYP2D6, cut the production of the metabolite oxymorphone by about 44 percent but did not meaningfully raise oxycodone itself.

The practical message is that a single enzyme inhibitor is unlikely to extend your detection window much. But if you happen to be taking both a CYP2D6 inhibitor (certain antidepressants like fluoxetine or paroxetine, for instance) and a CYP3A4 inhibitor (ketoconazole, itraconazole, clarithromycin, or grapefruit juice in large quantities), the combined effect can meaningfully slow how fast your body eliminates oxycodone.¹⁰ In that scenario, the 5 mg dose behaves more like a somewhat higher dose, and detection windows in urine and blood could stretch accordingly.

Why Urine Drug Tests Sometimes Get It Wrong

Standard workplace and clinical urine drug screens use immunoassay technology, which relies on antibodies that react when they encounter a drug or its metabolites. The problem is that these antibodies can cross-react with substances that have a similar chemical shape, producing a false positive.¹¹ Oxycodone is a semi-synthetic opioid, and older immunoassay panels designed to detect natural opioids like morphine and codeine may miss it entirely or detect it inconsistently. Newer panels include oxycodone-specific antibodies, but even these can have cross-reactivity issues.

For this reason, immunoassay results are considered preliminary and presumptive.¹² A positive immunoassay should always be confirmed with a more specific technique like gas chromatography-mass spectrometry, which can distinguish oxycodone from other opioids and from unrelated substances. If you are told you tested positive for opioids and you only took a legitimate 5 mg oxycodone prescription, request confirmatory testing. The confirmatory test will identify exactly which opioid is present and at what concentration, which matters if the question is whether the result is consistent with a prescribed dose.

Single Dose Versus Regular Use

Everything discussed so far applies to a single 5 mg dose, but many people taking oxycodone use it on a schedule. When patients took 10 mg every four hours (a standard dosing interval), researchers found no accumulation of oxycodone at steady state, with mean plasma concentrations holding at about 35 micrograms per liter.¹ “No accumulation” sounds reassuring, but it means the body is clearing each dose before the next one arrives, not that the drug disappears faster. For urine testing, chronic use extends detection windows because metabolites build up in tissues and are released gradually. A person taking oxycodone daily for weeks will test positive in urine for longer after stopping than someone who took one 5 mg pill once.

If you have been taking 5 mg once or twice daily for several days or longer and then stop, expect urine positivity to last two to four days rather than the roughly 30 to 40 hours seen with a single dose. The exact extension depends on how long you were taking it, your metabolism, and your kidney function.

Oxycodone in Breast Milk

This is a question that matters enormously to a specific group of readers: nursing mothers prescribed oxycodone for post-surgical or postpartum pain. Oxycodone concentrates in breast milk at levels higher than in the mother’s blood. Two separate studies found a median milk-to-plasma ratio of about 3.2 to 1, meaning milk contains roughly three times the oxycodone concentration of plasma.¹³¹⁴ One study detected oxycodone in breast milk up to 72 hours after a cesarean delivery, with some mothers showing levels above 100 ng/mL. The correlation between maternal plasma and milk levels was strong, so as the mother’s blood levels drop, milk levels fall too, but with a lag.

Despite the concerning concentration ratio, modeling suggests that breastfed infants would receive less than 10 percent of a weight-adjusted therapeutic infant dose, and the volumes of milk consumed in the first few days after birth are small.¹⁴ However, there have been reports of neonatal respiratory depression associated with maternal oxycodone use during breastfeeding, particularly when doses exceeded recommended levels.¹⁵ For a mother taking a single 5 mg dose, the risk to a nursing infant is very low, but monitoring the infant for unusual drowsiness or breathing changes is still sensible. The key point for this article’s question is that oxycodone persists in breast milk longer than in the mother’s blood, potentially up to 72 hours after dosing, because of the concentration effect and slower clearance from milk.

What Happens After Death

This section is relevant mainly to forensic investigators and families trying to understand a toxicology report, but it illustrates something important about how oxycodone behaves in the body. After death, drug concentrations in blood do not stay static. Oxycodone stored in organs like the liver and kidneys leaks back into the blood over hours and days, a phenomenon called postmortem redistribution. In a documented case, oxycodone levels in peripheral blood were more than ten times higher ten days after death than they were shortly after death, and central blood levels increased about six-fold over the same period.¹⁶ This means postmortem blood oxycodone concentrations can be wildly misleading if interpreted the same way a living person’s levels would be. A concentration that looks lethal on paper may partly reflect redistribution rather than the dose actually taken. Forensic toxicologists account for this by collecting blood from peripheral sites and comparing specimens taken at different times, but families and lawyers who see raw numbers in an autopsy report often do not have that context.